2016
DOI: 10.1021/acsinfecdis.6b00154
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Recognition of Muramyl Dipeptide Occurs in the Leucine-rich Repeat Domain of Nod2

Abstract: Genetic mutations in the innate immune receptor nucleotide-binding oligomerization domain-containing 2 (Nod2) have demonstrated increased susceptibility to Crohn’s disease, an inflammatory bowel disease which is hypothesized to be accompanied by changes in the gut microbiota. Nod2 responds to the presence of bacteria, specifically a fragment of the bacterial cell wall, muramyl dipeptide (MDP). The proposed site of this interaction is the leucine-rich repeat (LRR) domain. Surface plasmon resonance and molecular… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
66
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 43 publications
(74 citation statements)
references
References 36 publications
3
66
0
Order By: Relevance
“…MDP is linked to the surface via the C‐1 and the previously established C‐6 position (Figure A), allowing us to directly compare binding affinities for the site of modification. A concentration gradient of Nod2 LRR was applied to the surface and the binding affinities for both compounds were determined. Nod2 LRR binds to 6‐amino MDP with low nanomolar binding affinity (95(±9) n m ) in agreement with the literature (Figure B) .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…MDP is linked to the surface via the C‐1 and the previously established C‐6 position (Figure A), allowing us to directly compare binding affinities for the site of modification. A concentration gradient of Nod2 LRR was applied to the surface and the binding affinities for both compounds were determined. Nod2 LRR binds to 6‐amino MDP with low nanomolar binding affinity (95(±9) n m ) in agreement with the literature (Figure B) .…”
Section: Methodsmentioning
confidence: 99%
“…A concentration gradient of Nod2 LRR was applied to the surface and the binding affinities for both compounds were determined. Nod2 LRR binds to 6‐amino MDP with low nanomolar binding affinity (95(±9) n m ) in agreement with the literature (Figure B) . When ( 1 ) was attached to the surface via the C‐1 position, binding decreased to high nanomolar affinity (700(±100) n m ; Figure C).…”
Section: Methodsmentioning
confidence: 99%
“…Nucleotide‐binding oligomerization domain protein 2, initially described as a susceptibility gene for inflammatory bowel diseases such as Crohn’s disease, is an intracellular protein LRRs (containing leucine‐rich repeats) similar to those found in TLRs (Toll‐like receptors) [8]. As an intracellular PRR (pathogen recognition receptor), NOD2 perceives bacterial peptidoglycans from gram‐positive and gram‐negative bacteria, through its interaction with MDP (muramyl dipeptide) [9,10]. NOD2 is widely expressed in dendritic cells, macrophages, and at lower levels in intestinal epithelial cells and VSMCs [11].…”
Section: Introductionmentioning
confidence: 99%
“…RNA secreted from bacteria can also induce IFN-␤ production by activation of the cytosolic RIG-I sensor (19). A third possibility is that cell wall components released from the phagosome activated cytoplasmic NOD2 (41). Pore-forming toxins, including pneumolysin, have been suggested to deliver bacterial stimulatory molecules from the phagolysosome to the host cytosol, where interaction with pattern recognition receptors occurs, leading to IFN-␤ production (33,37).…”
Section: Discussionmentioning
confidence: 99%